PSIWM
NMTR

Paradigm Strategies in Wealth Management’s 9 Meters Biopharma NMTR Stock Holding History

Paradigm Strategies in Wealth Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,540
Closed -$40K – 52
2021
Q3 		$40K Buy
1,540
+1,000
+185% +$23.6K 0.04% 48
2021
Q2 		$12K Buy
+540
New +$13.3K 0.01% 161

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paradigm Strategies in Wealth Management's NMTR Position: Q4 2021 in Review

Paradigm Strategies in Wealth Management sold out of 9 Meters Biopharma (NMTR) in Q4 2021, closing a stake of 1,540 shares — an estimated $40K sold.

Paradigm Strategies in Wealth Management first reported a position in NMTR in Q2 2021 and held it in 2 quarters. The position peaked at $40K in Q3 2021. 104 funds tracked by Wall St. Rank hold NMTR as of Q4 2021.

  • Paradigm Strategies in Wealth Management reported no remaining 9 Meters Biopharma position as of Q4 2021 after selling out during the quarter.
  • Paradigm Strategies in Wealth Management sold 1,540 9 Meters Biopharma shares in Q4 2021, an estimated $40K.
  • Paradigm Strategies in Wealth Management first reported a position in 9 Meters Biopharma in Q2 2021 and held it in 2 quarters.
  • Paradigm Strategies in Wealth Management's 9 Meters Biopharma position peaked at $40K in Q3 2021.
  • 104 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2021.

Based on Paradigm Strategies in Wealth Management's 13F filing for Q4 2021, filed 8 Feb 2022.